Nomination Committee’s proposal regarding board of directors of Episurf Medical AB for 2024
Episurf Medical’s Nomination Committee proposes six regular board members without deputies, including the re-election of Ulf Grunander as chairman of the board and the proposed new election of Dr. Jess Lonner as board member, to be confirmed at the annual general meeting. Other board members are proposed for re-election. Ulf Grunander was elected chairman in 2023 and has been a board member since 2021. Other board members proposed for re-election are Board Members Leif Ryd (member since 2009), Christian Krüeger (member since 2016), Laura Shunk (member since 2017) and Annette Brodin Rampe (member since 2021).
The Nomination Committee proposes Dr. Jess Lonner as a new member of the board.
Dr. Lonner is a professor of Orthopaedic Surgery at Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, and an attending surgeon at the Rothman Orthopaedic Institute, where he specializes in the surgical treatment of knee arthritis. He has an extensive research portfolio, covering a variety of topics including partial and total knee replacement surgery, and robotic surgery. He has published several internationally acclaimed textbooks on knee replacement surgery and robotics, as well as hundreds of scientific papers. In addition, Dr. Lonner has been involved in the design and development of numerous knee replacement implant systems, together with some of the world’s market-leading implant manufacturers. After graduating with honors from Boston University School of Medicine, Dr. Lonner completed his Orthopaedic Surgery residency training at the Hospital for Joint Diseases in New York City. He subsequently completed his fellowship as a Harvard Fellow at the Massachusetts General Hospital in Boston. Before joining the Rothman Orthopaedic Institute in 2011, he served as both the Director of Knee Replacement Surgery and Director of the Joint Replacement Fellowship at Pennsylvania Hospital. He currently serves as a member of the Executive Board of the Knee Society, has previously served as President of the Philadelphia Orthopaedic Society and as a member of the American Association of Hip and Knee Surgeons. He is also an active member of the American Academy of Orthopaedic Surgeons.
“It is with great pleasure we propose Dr. Lonner as new board member of Episurf Medical. Episurf is taking great steps and the opportunities for the company’s technology are significant. Dr. Lonner’s background is perfect for us, and we are also strengthening our US presence”, says Sebastian Jahreskog, Chairman of the Nomination Committee, Episurf Medical.
“It is an honor to be nominated to join Episurf’s Board of Directors. The company’s dedication to helping middle-aged patients is one that’s been a particular interest throughout my career, and I look forward to helping the company in its continued development”, says Dr. Jess Lonner.
The 2024 AGM in Episurf Medical AB (publ) will be held on Tuesday April 9.
***
The Nomination Committee of Episurf Medical AB (publ)
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] => <p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><strong><span style="font-size:10pt">About Episurf Medical</span></strong></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.</em></p>
<p style="font-family:arial,helvetica,sans-serif; font-size:10pt"><span style="font-family:arial,helvetica,sans-serif; font-size:10pt"><em>The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CET on 4 March 2024.</em></span></p>
[HtmlContact:protected] => <p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><strong><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">For more information, please contact:</span></strong></p>
<p style="font-family: arial, helvetica, sans-serif; font-size: 10pt;"><span style="font-size: 10pt;">Pål Ryfors, CEO, Episurf Medical<br /></span><span style="font-size: 10pt; font-family: arial,helvetica,sans-serif;">Tel:</span><span style="font-size: 10pt;">+46 (0) 709 62 36 69<br /></span><span style="font-size: 10pt;">Email: </span><a href="mailto:pal.ryfors@episurf.com">pal.ryfors@episurf.com</a></p>
[HtmlTitle:protected] => <h1 style="line-height:120%"><span style="font-family:arial,helvetica,sans-serif"><strong>Nomination Committee’s proposal regarding board of directors of Episurf Medical AB for 2024</strong></span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical’s Nomination Committee proposes six regular board members without deputies, including the re-election of Ulf Grunander as chairman of the board and the proposed new election of Dr. Jess Lonner as board member, to be confirmed at the annual general meeting. Other board members are proposed for re-election. Ulf Grunander was elected chairman in 2023 and has been a board member since 2021. Other board members proposed for re-election are Board Members Leif Ryd (member since 2009), Christian Krüeger (member since 2016), Laura Shunk (member since 2017) and Annette Brodin Rampe (member since 2021).
The Nomination Committee proposes Dr. Jess Lonner as a new member of the board.
Dr. Lonner is a professor of Orthopaedic Surgery at Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, and an attending surgeon at the Rothman Orthopaedic Institute, where he specializes in the surgical treatment of knee arthritis. He has an extensive research portfolio, covering a variety of topics including partial and total knee replacement surgery, and robotic surgery. He has published several internationally acclaimed textbooks on knee replacement surgery and robotics, as well as hundreds of scientific papers. In addition, Dr. Lonner has been involved in the design and development of numerous knee replacement implant systems, together with some of the world’s market-leading implant manufacturers. After graduating with honors from Boston University School of Medicine, Dr. Lonner completed his Orthopaedic Surgery residency training at the Hospital for Joint Diseases in New York City. He subsequently completed his fellowship as a Harvard Fellow at the Massachusetts General Hospital in Boston. Before joining the Rothman Orthopaedic Institute in 2011, he served as both the Director of Knee Replacement Surgery and Director of the Joint Replacement Fellowship at Pennsylvania Hospital. He currently serves as a member of the Executive Board of the Knee Society, has previously served as President of the Philadelphia Orthopaedic Society and as a member of the American Association of Hip and Knee Surgeons. He is also an active member of the American Academy of Orthopaedic Surgeons.
“It is with great pleasure we propose Dr. Lonner as new board member of Episurf Medical. Episurf is taking great steps and the opportunities for the company’s technology are significant. Dr. Lonner’s background is perfect for us, and we are also strengthening our US presence”, says Sebastian Jahreskog, Chairman of the Nomination Committee, Episurf Medical.
“It is an honor to be nominated to join Episurf’s Board of Directors. The company’s dedication to helping middle-aged patients is one that’s been a particular interest throughout my career, and I look forward to helping the company in its continued development”, says Dr. Jess Lonner.
The 2024 AGM in Episurf Medical AB (publ) will be held on Tuesday April 9.
***
The Nomination Committee of Episurf Medical AB (publ)
[HtmlBody:protected] => <p style="margin-top:12px"><span><span style="font-size:11pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span style="color:black">Episurf Medical’s Nomination Committee proposes six regular board members without deputies, including the re-election of Ulf Grunander as chairman of the board and the proposed new election of Dr. Jess Lonner as board member, to be confirmed at the annual general meeting. Other board members are proposed for re-election. Ulf Grunander was elected chairman in 2023 and has been a board member since 2021. Other board members proposed for re-election are Board Members Leif Ryd (member since 2009), Christian Krüeger (member since 2016), Laura Shunk (member since 2017) and Annette Brodin Rampe (member since 2021).</span></span></span></span></span></span></p>
<p><span><span style="font-size:11pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span style="color:black">The Nomination Committee proposes Dr. Jess Lonner as a new member of the board. </span></span></span></span></span></span></p>
<p><span><span style="font-size:11pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span style="color:black">Dr. Lonner is a professor of Orthopaedic Surgery at Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, and an attending surgeon at the Rothman Orthopaedic Institute, where he specializes in the surgical treatment of knee arthritis. He has an extensive research portfolio, covering a variety of topics including partial and total knee replacement surgery, and robotic surgery. He has published several internationally acclaimed textbooks on knee replacement surgery and robotics, as well as hundreds of scientific papers. In addition, Dr. Lonner has been involved in the design and development of numerous knee replacement implant systems, together with some of the world’s market-leading implant manufacturers. After graduating with honors from Boston University School of Medicine, Dr. Lonner completed his Orthopaedic Surgery residency training at the Hospital for Joint Diseases in New York City. He subsequently completed his fellowship as a Harvard Fellow at the Massachusetts General Hospital in Boston. Before joining the Rothman Orthopaedic Institute in 2011, he served as both the Director of Knee Replacement Surgery and Director of the Joint Replacement Fellowship at Pennsylvania Hospital. He currently serves as a member of the Executive Board of the Knee Society, has previously served as President of the Philadelphia Orthopaedic Society and as a member of the American Association of Hip and Knee Surgeons. He is also an active member of the American Academy of Orthopaedic Surgeons.</span></span></span></span></span></span></p>
<p><span><span style="font-size:11pt"><span style="background-color:white"><span style="font-family:arial,helvetica,sans-serif"><em><span style="font-size:10pt"><span style="color:black">“It is with great pleasure we propose Dr. Lonner as new board member of Episurf Medical. Episurf is taking great steps and the opportunities for the company’s technology are significant. Dr. Lonner’s background is perfect for us, and we are also strengthening our US presence”,</span></span></em><span style="font-size:10pt"><span style="color:black"> says Sebastian Jahreskog, Chairman of the Nomination Committee, Episurf Medical. </span></span></span></span></span></span></p>
<p><span><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif"><em><span style="font-size:10pt">“It is an honor to be nominated to join Episurf’s Board of Directors. The company’s dedication to helping middle-aged patients is one that’s been a particular interest throughout my career, and I look forward to helping the company in its continued development”</span></em><span style="font-size:10pt">, says Dr. Jess Lonner.</span></span></span></span></p>
<p><span><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span>The 2024 AGM in Episurf Medical AB (publ) will be held on Tuesday April 9.</span></span></span></span></span></p>
<p>***</p>
<p><span><span style="font-size:11pt"><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span>T</span></span></span></span>he Nomination Committee of Episurf Medical AB (publ)</span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => EU Transparency SE
[Name:protected] => SeFsaCategoryCode
[Value:protected] => S10
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => OMX Filing (OMX CNS)
[Name:protected] => OMX CategoryCode
[Value:protected] => 072
)
[2] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 14747
)
[3] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Facebook
[Name:protected] => Facebook
[Value:protected] => 15508
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] => About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
The information was submitted for publication, through the agency of the contact person set out above, at 08.30 CET on 4 March 2024.
[Contact:protected] => For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Episealer
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3939753/2642207.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Nomination Committee’s proposal regarding board of directors of Episurf Medical AB for 2024
[Description:protected] => Nomination Committee’s proposal regarding board of directors of Episurf Medical AB for 2024
[CreateDate:protected] => 2024-03-04T07:30:14.347Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 4765063
[EncryptedId:protected] => 78ED6CB66CA7C199
[IsRegulatory:protected] => 1
[PublishDate:protected] => 2024-03-04T07:30:00Z
[LastChangeDate:protected] => 2024-03-04T07:30:14.317Z
[Title:protected] => Nomination Committee’s proposal regarding board of directors of Episurf Medical AB for 2024
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/nomination-committee-s-proposal-regarding-board-of-directors-of-episurf-medical-ab-for-2024,c3939753
[LanguageVersions:protected] => Array
(
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)